retatrutide wikipedia Partnership for Safe Medicines on Reels What to Know About Retatrutide

doi: 10.1007/s00125-019-4946-6 10 SorliCHarashimaSTsoukasGMUngerJKarsblJDHansenTet al

In Phase 3 clinical trials, participants on retatrutide lost up to 28.7% of their body weight in 68 weeks

At iQ Doctor, we offer safe, MHRA-approved treatments including: Both of these treatments are licensed in the UK for weight management and prescribed safely by registered healthcare professionals

Expert-Guided, Sustainable Weight Loss Discover how proven medications such as semaglutide or tirzepatide, combined with expert support, can help you reach lasting weight loss results

When appetite is severely suppressed (especially during the early weeks and after dose increases), prioritize protein over all other macronutrients

Mechanism Retatrutide is a triple agonist, targeting GIP, GLP-1, and glucagon receptors